Patient-reported outcomes in the Translational Breast Cancer Research Consortium.


Journal Article

Members of the Translational Breast Cancer Research Consortium conducted an expert-driven literature review to identify a list of domains and to evaluate potential measures of these domains for inclusion in a list of preferred measures. Measures were included if they were easily available, free of charge, and had acceptable psychometrics based on published peer-reviewed analyses. A total of 22 domains and 52 measures were identified during the selection process. Taken together, these measures form a reliable and validated list of measurement tools that are easily available and used in multiple cancer trials to assess patient-reported outcomes in relevant patients.

Full Text

Duke Authors

Cited Authors

  • Bowen, DJ; Shinn, EH; Gregrowski, S; Kimmick, G; Dominici, LS; Frank, ES; Smith, KL; Rocque, G; Ruddy, KJ; Pollastro, T; Melisko, M; Ballinger, TJ; Fayanju, OM; Wolff, AC

Published Date

  • March 1, 2020

Published In

Volume / Issue

  • 126 / 5

Start / End Page

  • 922 - 930

PubMed ID

  • 31743427

Pubmed Central ID

  • 31743427

Electronic International Standard Serial Number (EISSN)

  • 1097-0142

Digital Object Identifier (DOI)

  • 10.1002/cncr.32615


  • eng

Conference Location

  • United States